Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Baron Health Care Fund outperformed its healthcare benchmark in Q3 2025, led by strong biotech stock selection. The manager utilized market volatility to selectively add 16 new positions, prioritizing durable growth compounders with clear secular advantages.
Full Quick Take
Baron Health Care Fund outperformed its healthcare benchmark in Q3 2025, led by strong biotech stock selection. The manager utilized market volatility to selectively add 16 new positions, prioritizing durable growth compounders with clear secular advantages.
In a difficult quarter for the broader Health Care sector, the Baron Health Care Fund declined 9.58% (Institutional Shares), roughly in line with its benchmark. Despite near-term policy uncertainty under the new administration, the manager remains bullish on long-term health care innovation, particularly in biotechnology, medical devices, and life sciences tools.
Full Quick Take
In a difficult quarter for the broader Health Care sector, the Baron Health Care Fund declined 9.58% (Institutional Shares), roughly in line with its benchmark. Despite near-term policy uncertainty under the new administration, the manager remains bullish on long-term health care innovation, particularly in biotechnology, medical devices, and life sciences tools.
